Angiotensin II blockade decreases TGF-β1 and matrix proteins in cyclosporine nephropathy

Kidney International

Volumn 52, Issue 3, 1997, Pages 660-673

  Shihab, Fuad S ^a   Bennett, William M ^b   Tanner, Amie M ^b   Andoh, Takeshi F ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Angiotensin II; Cyclosporine; Enalapril; Fibrosis; Losartan; Nephrotoxicity

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN II ANTAGONIST; CREATININE; CYCLOSPORIN; CYCLOSPORIN A; ENALAPRIL; HYDRALAZINE; HYDROCHLOROTHIAZIDE; LOSARTAN; MESSENGER RNA; NILVADIPINE; OLIVE OIL; PLACEBO; PLASMINOGEN ACTIVATOR INHIBITOR 1; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; EXTRACELLULAR MATRIX; GENE EXPRESSION; GLOMERULUS FILTRATION RATE; INTERSTITIAL NEPHRITIS; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FIBROSIS; MALE; NEPHROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM DEPLETION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030801946     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.380     Document Type: Article

References (69)

1. KAHAN BD: Cyclosporine. N Engl J Med 321:1725-1738, 1989
2. BENNETT WM, DEMATTOS A, MEYER MM, ANDOH T, BARRY JM: Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy. Kidney Int 50:1089-1100, 1996
3. MYERS BD, ROSS JC, NEWTON LD, LUETSCHER JA, PERLROTH MG: Cyclosporine-associated chronic nephropathy. N Engl J Med 311:600-705, 1984
4. ROSEN S, GREENFELD Z, BREZIS M: Chronic cyclosporine-induced nephropathy in the rat. Transplantation 49:445-452, 1990
5. ELZINGA LW, ROSEN S, BENNETT WM: Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy: Role of sodium intake. J Am Soc Nephrol 4:214-221, 1993
6. BORDER WA, NOBLE NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
7. SHIHAB FS, ANDOH TF, TANNER AM, NOBLE NA, BORDER WA, FRANCESCHINI N, BENNETT WM: Role of transforming growth factor-β1 in experimental chronic cyclosporine nephropathy. Kidney Int 49:1141-1151, 1996
8. PRASHAR Y, KHANNA A, SEHAJPAL P, SHARMA VK, SUTHANTHIRAN M: Stimulation of transforming growth factor-β1 transcription by cyclosporine. FEBS Lett 358:109-112, 1995
9. SHEHATA M, COPE GH, JOHNSON TS, RAFTERY AT, EL NAHAS AM: Cyclosporine enhances the expression of TGF-β in the juxtaglomerular cells of the rat kidney. Kidney Int 48:1487-1496, 1995
10. ICHIKAWA I, HARRIS RC: Angiotensin actions in the kidney: renewed insight into the old hormone. Kidney Int 40:583-596, 1991
11. WOLF G, NEILSON EG: Angiotensin II as a renal growth factor. J Am Soc Nephrol 3:1531-1540, 1993
12. JOHNSON RJ, ALPERS CE, YOSHIMURA A, LOMBARDI D, PRITZL P, FLOEGE J, SCHWARTZ S: Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464-474, 1992
13. LAFAYETTE RA, MAYER G, PARK SK, MEYER TW: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 90:766-771, 1992
14. KEANE WF, ANDERSON S, AURELL M, DE ZEEUW D, NARINS G, POVAR G: Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Ann Intern Med 118:577-581, 1993
15. RAVID M, SAVIN H, JUTRIN I, BENTAL T, KATZ B, LISHNER M: Long term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 118:577-581, 1993
16. KAKINUMA Y, KAWAMURA T, BILLS T, YOSHIOKA T, ICHIKAWA I, FOGO A: Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure. Kidney Int 42:46-55, 1992
17. ITOH H, MUKOYAMA M, PRATT RE, GIBBONS GH, DZAU VJ: Multiple autocrine growth factors modulate vascular smooth muscle cell growth responses to angiotensin II. J Clin Invest 91:2268-2274, 1993
18. KAGAMI S, BORDER WA, MILLER DE, NOBLE NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
19. WOLF G, SHARMA K, CHEN Y, ERICKSEN M, ZIYADEH FN: High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β. Kidney Int 42:647-656, 1992
20. BURDMANN EA, ANDOH TF, NAST CC, EVAN A, CONNORS BA, COFFMAN TM, LINDSLEY J, BENNETT WM: Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril. Am J Physiol 269:F491-F499, 1995
21. PICHLER RH, FRANCESCHINI N, YOUNG BA, HUGO C, ANDOH TF, BURDMANN EA, SHANKLAND SJ, ALPERS CE, BENNETT WM, COUSER WG, JOHNSON RJ: Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin. J Am Soc Nephrol 6:1186-1196, 1995
22. BENNETT WM, PORTER GA: Cyclosporine-associated hypertension. Am J Med 85:131-133, 1988
23. WONG PC, PRICE WJ, CHIU AT, DUNCIA JV, CARINI DJ, WEXLER RR, JOHNSON AL, TIMMERMANS PB: Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Hypertension 15:459-468, 1990
24. ANDERSON S, MEYER TW, RENNKE HG, BRENNER BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76:612-619, 1985
25. DERYNCK R, JARRETT JA, CHEN EY, GOEDDEL DV: The murine transforming growth factor-β precursor. J Biol Chem 261:4377-4379, 1986
26. ZEHEB R, GELEHRTER TD: Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1. Gene 73:459-468, 1988
27. FISHER LW, TERMINE JD, YOUNG MF: Deduced protein sequence of small proteoglycan 1 (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J Biol Chem 264:4571-4576, 1989
28. GENOVESE C, ROWE D, KREAM B: Construction of DNA sequences complementary to rat α1 and α2 collagen mRNA and their use in studying the regulation of type 1 collagen synthesis by 1,25-dihydroxyvitamin D. Biochemistry 23:6210-6216, 1984
29. FORT P, MARTY L, PIECHACZYK M, EL SABOURY S, DANI C, JEANTEUR P, BLANCHARD JM: Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate dehydrogenase multigenic family. Nucl Acid Res 13:1431-1442, 1985
30. WOOD L, THERIAULT N, VOGELI G: cDNA clones completing the nucleotide and derived amino acid sequence of the alpha 1 chain of basement membrane (type IV) collagen from mouse. FEBS Lett 227:5-8, 1988
31. SHIHAB FS, YAMAMOTO T, NAST CC, COHEN AH, NOBLE NA, GOLD LI, BORDER WA: Transforming growth factor-β and matrix protein expression in acute and chronic rejection of human renal allografts. J Am Soc Nephrol 6:286-294, 1995
32. RENNARD SI, BERG R, MARTIN GR, FOIDART JM, ROBEY PG: Enzyme-linked immunoassay (ELISA) for connective tissue components. Anal Biochem 104:205-214, 1980
33. SHIHAB FS, TANNER AM, SHAO Y, WEFFER MI: Expression of TGF-β1 and matrix proteins is elevated in rats with chronic rejection. Kidney Int (in press)
34. RUSCETTI FW, PALLADINO MA: Transforming growth factor-β and the immune system. Prog Growth Factor Res 3:159-175, 1991
35. KHANNA A, LI B, SEHAJPAL PK, SHARMA VK, SUTHANTHIRAN M: Mechanism of action of cyclosporine: A new hypothesis implicating transforming growth factor-β. Transplant Rev 9:41-48, 1995
36. HOU J, KATO H, COHEN RA, CHOBANIAN AV, BRECHER P: Angiotensin II-induced cardiac fibrosis in the rat is increased by chronic-inhibition of nitric oxide synthase. J Clin Invest 96:2469-2477, 1995
37. SUN Y, WEBER KT: Angiotensin converting enzyme and wound healing in diverse tissues of the rat. J. Lab Clin Med 127:94-101, 1996
38. SUN Y, WEBER KT: Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. J Mol Cell Cardiol 28:851-858, 1996
39. KATO H, HOU J, CHOBANIAN AV, BRECHER P: Effects of angiotensin II infusion and inhibition of nitric oxide synthase on the rat aorta. Hypertension 28:153-158, 1996
40. WARD WF, MOLTENI A, TS'AO CH: Radiation-induced endothelial dysfunction and fibrosis in rat lung: modification by the angiotensin converting enzyme inhibitor CL242817. Radiat Res 117:342-350, 1989
41. OU R, SUN Y, GANJAM VK, WEBER KT: In situ production of angiotensin II by fibrosed rat pericardium. J Mol Cell Cardiol 28:1319-1327, 1996
42. LEVY BI, BENESSIANO J, HENRION D, CAPUTO L, HEYMES C, DURIEZ M, POITEVIN P, SAMUEL JL: Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest 98:418-425, 1996
43. TAKEMOTO M, EGASHIRA K, USUI M, NUMAGUCHI K, TOMITA H, TSUTSUI H, SHIMOKAWA H, SUEISHI K, TAKESHITA A: Important role of tissue angiotensin- converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest 99:278-287, 1997
44. NAKAMURA T, MILLER D, RUOSLAHTI E, BORDER WA: Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-β1. Kidney Int 41:1213-1221, 1990
45. IGNOTZ RA, MASSAGUE J: Transforming growth factor beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261:4337-4345, 1986
46. BALZA E, BORSI L, ALLEMANNI G, ZARDI L: Transforming growth factor β regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. FEBS Lett 228:42-44, 1988
47. LAIHO M, SAKSELA O, KESKI-OJA J: Transforming growth factor-β induction of type-1 plasminonen activator inhibitor. J Biol Chem 262:17467-17474, 1987
48. FOX J, GUAN S, HYMEL AA, NAVAR LG: Dietary Na and ACE inhibition effects on renal tissue angiotensin I and II and ACE activity in rats. Am J Physiol 262:F902-F909, 1992
49. HOLMER S, ECKARDT K-U, LEHIR M, SCHRICKER K, RIEGGER G, KURTZ A: Influence of dietary NaCl intake on renin gene expression in the kidneys and adrenal glands of rats. Pflügers Arch 425:62-67, 1993
50. MASON J, MULLER-SCHWEINITZER E, DUPONT M, CASELLAS D, MIHATSCH M, MOORE L, KASKEL F: Cyclosporine and the renin-angiotensin system. Kidney Int 39(Suppl 32):S28-S32, 1991
51. BANTLE JP, NATH KA, SUTHERLANT DE, NAJARIAN JS, FERRIS TF: Effects of cyclosporin on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients. Arch Int Med 145:505-508, 1985
52. MYERS BD, SIBLEY R, NEWTON L, TOMLANOVICH SJ, BOSHKOS C, STINSON E, LUETSCHER JA, WHITNEY DJ, KRASNY D, COPLON NS, PURLROTH MG: The long-term course of cyclosporin-associated chronic nephropathy. Kidney Int 33:590-600, 1988
53. JULIEN J, FARGE D, KREFT-JAIS C, THANH-TAM P, PIERRE-FRANÇOIS P, HOUSSIN D, CARPENTIER A, CORVOL P: Cyclosporine-induced stimulation of the renin- angiotensin system after liver and heart transplantation. Transplantation 56:885-891, 1993
54. GARDINER DS, WATSON MA, JUNOR BR, BRIGGS JD, MORE IAR, LINDOP GBM: The effect of conversion from cyclosporin A to azathioprine on renin-containing cells in renal allograft biopsies. Nephrol Dial Transplant 6:363-367, 1991
55. LASKOW DA, CURTIS JJ, LUKE RG, JULIAN BA, JONES P, DEIERHOI MH, BARBER WH, DIETHELM AG: Cyclosporine-induced changes in glomerular filtration rate and urea excretion. Am J Med 88:497-502, 1990
56. DIEPERINK H, HANSEN HV, KEMP M, LEYSSAC PP, STARKLINT H, KEMP E: Antagonist capacity of felodipine on cyclosporin A nephrotoxicity in the rat. Nephrol Dial Transplant 7:1124-1129, 1992
57. KON V, HUNLEY TE, FOGO, A: Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Transplantation 60:89-95, 1995
58. LAFAYETTE RA, MAYER G, MEYER TW: The effects of blood pressure-reduction on cyclosporin nephrotoxicity in the rat. J Am Soc Nephrol 3:1892-1899, 1993
59. SECHI LA, GRADY EF, GRIFFIN CA, KALINYAK JE, SCHAMBELAN M: Distribution of angiotensin II receptor subtypes in rat and human kidney. Am J Physiol 262:F236-F240, 1992
60. ZHUO J, ALCORN D, HARRIS PJ, MENDELSOHN FAO: Localization and properties of angiotensin II receptors in rat kidney. Kidney Int 44(Suppl 42):S40-S46, 1993
61. OHTA K, KIM S, HAMAGUCHI A, YUKIMURA T, MIURA K, TAKAORI K, IWAO H: Role of angiotensin II in extracellular matrix and transforming growth factor-β1 expression in hypertensive rats. Eur J Pharmacol 269:115-119, 1994
62. KIM S, OHTA K, HAMAGUCHI A, OMURA T, YUKIMURA T, MIURA K, INADA Y, WADA T, ISHIMURA Y, CHATANI F, IWAO H: Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury. Kidney Int 46:1346-1358, 1994
63. PIMENTEL JL JR, SUNDELL CL, WANG S, KOPP JB, MONTERO A, MARTINEZ-MALDONADO M: Role of angiotensin II in the expression and regulation of transforming growth factor-β in obstructive nephropathy. Kidney Int 48:1233-1246, 1995
64. RUIZ-ORTEGA M, GONZALEZ S, SERON D, CONDOM E, BUSTOS C, LARGO R, GONZALEZ E, ORTIZ A, EGIDO J: ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. Kidney Int 48:1778-1891, 1995
65. ISHIDOYA S, MORRISSEY J, MCCRACKEN R, KLAHR S: Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int 49:1110-1119, 1996
66. OLSON JA JR, SHIVERICK KT, OGILVIE S, BUHI WC, RAIZADA MK: Angiotensin II induces secretion of plasminogen activator inhibitor 1 and a tissue metalloprotease inhibitor-related protein from rat brain astrocytes. Proc Natl Acad Sci USA 88:1928-1932, 1991
67. ZELEZNA B, RYDZEWSKI B, LU D, OLSON JA, SHIVERICK KT, TANG W, SUMNERS C, RAIZADA MK: Angiotensin II-induction of plasminogen activator inhibitor-1 gene expression in astroglial cells of normotensive and spontaneously hypertensive rat brain. Mol Endocrinol 6:2009-2017, 1992
68. ARAI M, WADA A, ISAKA Y, AKAGI Y, SUGIURA T, MIYAZAKI M, MORIYAMA T, KANEDA Y, NARUSE K, NARUSE M: In vivo transfection of genes for renin and angiotensinogen into the glomerular cells induced phenotypic change of the mesangial cells and glomerular sclerosis. Biochem Biophys Res Commun 206:525-532, 1995
69. BARICOS WH, CORTEZ SL, EL DAHR SS, SCHNAPER HW: ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int 47:1039-1047, 1995